Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Solid Biosciences (SLDB) FCF Margin (2021 - 2024)

Solid Biosciences' FCF Margin history spans 4 years, with the latest figure at 38926.67% for Q4 2024.

  • For Q4 2024, FCF Margin changed N/A year-over-year to 38926.67%; the TTM value through Dec 2024 reached 29415.29%, down 1183255.0%, while the annual FY2024 figure was 29415.29%, N/A changed from the prior year.
  • FCF Margin for Q4 2024 was 38926.67% at Solid Biosciences, up from 29436.59% in the prior quarter.
  • Across five years, FCF Margin topped out at 38926.67% in Q4 2024 and bottomed at 1426.18% in Q1 2022.
  • The 4-year median for FCF Margin is 11995.56% (2023), against an average of 13697.16%.
  • The largest annual shift saw FCF Margin crashed -78447bps in 2022 before it surged 2498073bps in 2023.
  • A 4-year view of FCF Margin shows it stood at 529.32% in 2021, then surged by 182bps to 436.57% in 2022, then soared by 5492bps to 24414.41% in 2023, then soared by 59bps to 38926.67% in 2024.
  • Per Business Quant, the three most recent readings for SLDB's FCF Margin are 38926.67% (Q4 2024), 29436.59% (Q3 2024), and 24394.32% (Q2 2024).